Correlation Between Replimune and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Replimune and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Replimune and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Day One.

Diversification Opportunities for Replimune and Day One

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Replimune and Day is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Replimune i.e., Replimune and Day One go up and down completely randomly.

Pair Corralation between Replimune and Day One

Given the investment horizon of 90 days Replimune Group is expected to generate 2.34 times more return on investment than Day One. However, Replimune is 2.34 times more volatile than Day One Biopharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest  1,053  in Replimune Group on September 9, 2024 and sell it today you would earn a total of  255.00  from holding Replimune Group or generate 24.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Replimune Group  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Replimune Group 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Replimune and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Replimune and Day One

The main advantage of trading using opposite Replimune and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Replimune Group and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Directory
Find actively traded commodities issued by global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance